What to make of Medtronic (NYSE:MDT) CEO Bill Hawkins’ decision to postpone his retirement?
A spokesman for the Fridley, Minn.-based company declined to answer any questions about the search for a new chief executive.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
What to make of Medtronic (NYSE:MDT) CEO Bill Hawkins’ decision to postpone his retirement?
A spokesman for the Fridley, Minn.-based company declined to answer any questions about the search for a new chief executive.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Johnson & Johnson (NYSE:JNJ) took another step towards its $2.4 billion acquisition of Crucell N.V. (NSDQ:CRXL).
The companies announced that the minimum acceptance condition of Johnson & Johnson’s offer to acquire Crucell was satisfied.
When the offer expired on Feb. 16, the shares tendered in the deal represent 95 percent of the issued and outstanding share capital of Crucell on a fully diluted basis.
Neogen profits jump 33 percent
Neogen Corp. (NSDQ:NEOG) posted profits of $6.1 million, or 26 cents per diluted share, on sales of $43.9 million during the three months ended Nov. 30. That compares with profits of $4.6 million, or 20 cents per diluted share, on sales of $35.3 million during the same period last year.
BSD Medical Corp. (NSDQ:BSDM) landed 510(k) clearance from the Food & Drug Administration for itsits MicroThermX microwave ablation system, MTX-180.
The Salt Lake City-based cancer treatment device-maker said it optimized the MTX-180 system with higher power for interventional and surgical oncology. The device uses "synchronous phased array technology" to target microwave energy for soft-tissue ablation.